Kevin R. Lind
Overview
Kevin R. Lind received an average of $2M in total compensation, including $515K in salary, at Longboard Pharmaceuticals from 2020 to 2023. Kevin Lind also received $1M at Arena Pharmaceuticals in 2016.
- 2023
- 2022
- 2021
- 2020
- 2016
Longboard PharmaceuticalsPresident and Chief Executive Officer
Longboard PharmaceuticalsPresident and Chief Executive Officer
Longboard PharmaceuticalsPresident and Chief Executive Officer
Longboard PharmaceuticalsPresident and Chief Executive Officer
Arena PharmaceuticalsExecutive Vice President, Chief Financial Officer
Source: SEC filings on April 12, 2024, April 11, 2023, April 13, 2022, and April 28, 2017.
Related executives
We found 12 more executives who work or worked at Longboard Pharmaceuticals and Arena Pharmaceuticals.
Randall Kaye
Longboard Pharmaceuticals
Chief Medical Officer
Brandi Roberts
Longboard Pharmaceuticals
Chief Financial Officer
Philip Perera
Longboard Pharmaceuticals
Chief Medical Officer
Amit Munshi
Arena Pharmaceuticals
Chief Executive Officer
Dominic Behan
Arena Pharmaceuticals
Chief Scientific Officer
Steven Spector
Arena Pharmaceuticals
General Counsel
Craig Audet
Arena Pharmaceuticals
Former Senior Vice President, Operations and Head of Global Regulatory Affairs
Vincent Aurentz
Arena Pharmaceuticals